D. Swanson

发表

Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

A. El‐Naggar, C. Dinney, I. Fidler, 2001, The American journal of pathology.

Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience.

D. Kuban, Andrew K. Lee, L. Levy, 2009, Urology.

Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.

C. Dinney, A. V. von Eschenbach, C. Pettaway, 1995, The Journal of urology.

Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer.

T. Pugh, R. Kudchadker, S. Frank, 2013, Brachytherapy.

Endorectal MRI for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy

D. Kuban, S. McGuire, Andrew K. Lee, 2014 .

An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial.

T. Pugh, L. Levy, R. Kudchadker, 2013, Brachytherapy.

Establishing high-quality prostate brachytherapy using a phantom simulator training program.

D. Kuban, L. Potters, M. Keyes, 2014, International journal of radiation oncology, biology, physics.

Magnetic resonance imaging-based treatment planning for prostate brachytherapy.

T. Pugh, R. Kudchadker, J. Albert, 2013, Brachytherapy.

Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi.

C. Wood, S. Swisher, C. Dinney, 2003, Urologic oncology.

Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.

A. Pollack, G. Zagars, D. Swanson, 1994, International journal of radiation oncology, biology, physics.

Salvage cystectomy for bladder carcinoma

A. V. von Eschenbach, D. Swanson, R. Bracken, 1981, Cancer.

Preoperative radiotherapy for muscle‐invasive bladder carcinoma. Long term follow‐up and prognostic factors for 338 patients

C. Dinney, A. V. von Eschenbach, A. Pollack, 1994, Cancer.

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.

C. Dinney, A. V. von Eschenbach, A. Pollack, 1995, International journal of radiation oncology, biology, physics.

Metastasectomy for renal cell carcinoma

D. Swanson, 2004, Der Urologe.

Surgery for Metastases of Renal Cell Carcinoma

D. Swanson, 2004, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

A renal mass in the setting of a nonrenal malignancy

C. Wood, Yu Shen, S. Wen, 2004, Cancer.

Genitourinary Oncology Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing

D. Kuban, L. Potters, M. Zelefsky, 2016 .

"Silent" osseous metastases in renal cell carcinoma: value of computerized tomography.

M. Bernardino, D. Swanson, 1982, Urology.

Clinical stage i nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone

C. Logothetis, C. Dunphy, J. Ro, 1988, Cancer.

Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance.

R. Babaian, A. V. von Eschenbach, C. Dunphy, 1989, Urology.

Defining a standard set of patient-centered outcomes for men with localized prostate cancer.

Steven J Frank, Thomas Wiegel, Ronald C. Chen, 2014, European urology.

Original Articles: Bladder Cancer: Management of Transitional Cell Carcinoma Involving Von Brunn's Nests

C. Dinney, R. Babaian, A. V. von Eschenbach, 1995 .

Role of nuclear grading in stage I renal cell carcinoma.

D. Grignon, L. Green, G. Giacco, 1989, Urology.

Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.

C. Dinney, J. Nesbitt, D. Schrump, 1997, The Annals of thoracic surgery.

Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer.

T. Pugh, R. Kudchadker, V. Takiar, 2014, Brachytherapy.

OUTCOME OF BLADDER CANCER PATIENTS WITH pN+ DISEASE AFTER PREOPERATIVE CHEMOTHERAPY AND RADICAL CYSTECTOMY

M. Munsell, A. Kamat, W. Kassouf, 2009 .

Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.

H. Grossman, C. Dinney, M. Munsell, 2009, Urology.

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

R. Millikan, H. Grossman, C. Wood, 2003, The Journal of urology.

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.

R. Millikan, C. Dinney, C. Logothetis, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.

P. Pisters, B. Mian, L. Pisters, 2002, The Journal of urology.

Oncological efficacy and safety of nephron‐sparing surgery for selected patients with locally advanced renal cell carcinoma

V. Margulis, P. Tamboli, C. Wood, 2007, BJU international.

Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience.

R. Millikan, C. Logothetis, Yu Shen, 2004, The Journal of urology.

Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1986, The American journal of medicine.

Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1985, The Journal of urology.

Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma.

C. Dinney, J. Nesbitt, L. Pisters, 1997, Urology.

Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.

R. Amato, J. Ro, A. Ayala, 2004, Urology.

Chemotherapy of extragonadal germ cell tumors.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Stage I Nonseminomatous and Mixed Germ Cell Tumors of the Testis: A Clinicopathologic Study of 93 Patients on a Surveillance Protocol after Orchiectomy Alone

C. Logothetis, C. Dunphy, J. Ro, 1989 .

Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation

M. Ross, O. Eton, K. Itoh, 1993, Cancer Immunology, Immunotherapy.

The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

R. Millikan, C. Dinney, A. Kamat, 2006, The Journal of urology.

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

J. Quesada, J. Gutterman, D. Swanson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative spindle cell nodule of the prostate and bladder.

D. Grignon, N. Ordóñez, J. Ro, 1990, The Journal of urology.

Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma.

C. Dinney, J. Slaton, D. Swanson, 1998, The Journal of urology.

Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomy.

A. K. Levinson, D. Grignon, R. Babaian, 1992, Urology.

Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery.

J. Putnam, D. Swanson, S. Tanguay, 1996, The Journal of urology.

Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?

C. Wood, C. Dinney, S. Matin, 2006, BJU international.

Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1985, The Journal of urology.

Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma.

C. Wood, C. Rosser, D. Swanson, 2004, The Journal of urology.

Should chemotherapy replace retroperitoneal lymphadenectomy for clinical stage II testicular tumors?

D. Swanson, 1995, Mayo Clinic proceedings.

Permanent Seed Implantation Prostate Brachytherapy for Intermediate Risk Prostate Cancer: Efficacy and Toxicity Outcomes from a Prospective Cohort of 300 Patients

T. Pugh, R. Kudchadker, P. Blanchard, 2016 .

Declining use of brachytherapy for the treatment of prostate cancer.

Andrew G. Lee, D. Kuban, K. Hoffman, 2013, Brachytherapy.

Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.

J. Quesada, J. Gutterman, D. Swanson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis: preliminary results.

A. V. von Eschenbach, D. Johnson, D. Swanson, 1984, The Journal of urology.

Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder.

G. Zagars, D. Swanson, A. Liles, 1990, The Journal of urology.

Angioinfarction plus nephrectomy for metastatic renal cell carcinoma--an update.

S. Wallace, A. V. von Eschenbach, D. Johnson, 1983, The Journal of urology.

Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.

C. Wood, P. Troncoso, R. Babaian, 2009, European urology.

Therapy and prognosis for male anterior urethral carcinoma: an update.

C. Dinney, R. Babaian, A. V. von Eschenbach, 1994, Urology.

Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy.

C. Logothetis, A. Shirkhoda, A. Sella, 1989, European journal of cancer & clinical oncology.

Role of intravesical mitomycin C in management of superficial bladder tumors.

A. V. von Eschenbach, S. Crooke, D. Johnson, 1980, Urology.

Two courses of chemotherapy after orchidectomy for high‐risk clinical stage i nonseminomatous testicular tumours

D. Swanson, 2005, BJU international.

Sarcomatoid renal cell carcinoma: Clinicopathologic. A study of 42 cases

J. Ro, A. Sella, A. Ayala, 1987, Cancer.

Renal cell carcinoma. A clinicopathologic and dna flow cytometric analysis of 103 cases

D. Grignon, G. Giacco, K. Wishnow, 1989, Cancer.

DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma

D. Grignon, L. Green, P. Troncoso, 1989, Cancer.

Renal cell carcinoma: antitumor effects of leukocyte interferon.

J. Quesada, J. Gutterman, D. Swanson, 1983, Cancer research.

Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.

V. Margulis, P. Tamboli, E. Jonasch, 2009, Urology.

Late rectal complications after prostate brachytherapy for localized prostate cancer

L. Levy, R. Kudchadker, J. Phan, 2009, Cancer.

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

N. Rioux-Leclercq, F. Guillé, J. Patard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Specific Androgen Receptor Activation by an Artificial Coactivator*

G. Jenster, A. V. von Eschenbach, K. Bramlett, 1999, The Journal of Biological Chemistry.

Pseudosarcomatous fibromyxoid tumor of the urinary bladder.

R. Babaian, N. Ordóñez, J. Ro, 1986, American journal of clinical pathology.

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

R. Millikan, H. Grossman, C. Dinney, 2004, The Journal of urology.

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder

B. Czerniak, C. Dinney, M. Munsell, 2007, Cancer.

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

N. Rioux-Leclercq, F. Guillé, J. Patard, 2005 .

Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.

J. Patard, J. Lam, R. Figlin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

R. Figlin, A. Belldegrun, C. Wood, 2003, The Journal of urology.

Strategies of management for advanced or recurrent kidney, adrenal, and miscellaneous genitourinary cancers

D. Swanson, 1987, Cancer.

Closed suction or penrose drainage after partial nephrectomy: does it matter?

C. Wood, S. Canfield, D. Swanson, 2004, The Journal of urology.

Fibrin glue for partial nephrectomy.

A. K. Levinson, R. Stephenson, D. Johnson, 1991, Urology.

Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion.

L. Pisters, J. Slaton, S. Donat, 1999, The Journal of urology.

Conservative surgery in solitary and bilateral renal carcinoma: indications and technical considerations.

D. Swanson, J. Palmer, 1978, Journal of Urology.

Complications of radical cystectomy: impact of the timing of perioperative chemotherapy.

C. Dinney, D. Swanson, M. Hall, 1996, Urology.

Complications of transabdominal radical nephrectomy for renal cell carcinoma.

D. Swanson, P. M. Borges, Philip M. Borges, 1983, The Journal of urology.

Predeposit autologous blood transfusions in patients undergoing irradiation and radical cystectomy.

D. Swanson, B. Lichtiger, R. Lo, 1983, The Journal of urology.

Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.

C. Wood, A. Kamat, S. Canfield, 2006, The Journal of urology.

Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.

C. Dinney, J. Slaton, D. Swanson, 1998, The Journal of urology.

Effective outpatient use of polyethylene glycol-electrolyte bowel preparation for radical cystectomy and ileal conduit urinary diversion.

R. Babaian, A. V. von Eschenbach, K. Wishnow, 1988, Urology.

Future prognostic factors for renal cell carcinoma

A. Boynton, K. Halling, D. Swanson, 1997, Cancer.

Redefining pT3 renal cell carcinoma in the modern era

V. Margulis, P. Tamboli, C. Wood, 2007, Cancer.

Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma

V. Margulis, P. Tamboli, C. Wood, 2008, Cancer.

Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.

V. Margulis, P. Tamboli, C. Wood, 2009, The Journal of urology.

Osseous metastases secondary to renal cell carcinoma.

G. Giacco, D. Johnson, D. Swanson, 1981, Urology.

The role of embolization and nephrectomy in the treatment of metastatic renal carcinoma.

S. Wallace, D. Johnson, D. Swanson, 1980, The Urologic clinics of North America.

Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.

P. Tamboli, E. Jonasch, C. Wood, 2007, The Journal of urology.

Surgery following response to interferon-α-based therapy for residual renal cell carcinoma

C. Logothetis, R. Amato, J. Putnam, 1993 .

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

R. Babaian, C. Logothetis, K. Wishnow, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sarcomatoid renal cell carcinoma. A treatable entity

C. Logothetis, J. Ro, A. Sella, 1987, Cancer.

Clear cell melanoma of the bladder.

N. Ordóñez, J. Ro, D. Swanson, 1993, Ultrastructural pathology.

Bladder metastasis: A rare cause of hematuria in renal carcinoma

D. Swanson, A. Liles, 1982, Journal of surgical oncology.

Relationship of thyroid disease to renal cell carcinoma. An epidemiologic study.

A. V. von Eschenbach, D. Swanson, F. Dexeus, 1990, Urology.

Conservative management of the retroperitoneum for stages I and II nonseminomatous germ cell tumors

M. Gleave, D. Swanson, A. C. Eschenbach, 1992, World Journal of Urology.

Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma.

C. Logothetis, R. Amato, J. Putnam, 1993, The Journal of urology.

The relationship of local control to distant metastasis in muscle invasive bladder cancer.

H. Grossman, C. Dinney, A. Pollack, 1995, The Journal of urology.

Optimal delivery of perioperative chemotherapy: preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma.

C. Dinney, C. Logothetis, A. V. von Eschenbach, 1996, The Journal of urology.

Renal Cell Carcinoma: Antitumor Effects of Leukocyte Interferon 1

J. Gutterman, R. Quesada, D. Swanson, 2007 .

Vesicourethral anastomosis with 2-octyl cyanoacrylate adhesive in an in vivo canine model.

A. Costello, L. Stephens, D. Swanson, 2002, Urology.

Estramustine phosphate (Emcyt) as treatment for metastatic renal carcinoma.

D. Johnson, D. Swanson, D. Johnson, 1981, Urology.

Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy

R. Babaian, A. Kamat, C. Rosser, 2006, Cancer.

The efficacy and complications of salvage cryotherapy of the prostate.

C. Dinney, R. Babaian, A. V. von Eschenbach, 1997, The Journal of urology.

Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.

P. Tamboli, E. Jonasch, C. Wood, 2007, The Journal of urology.

The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.

D. Swanson, 1993, Seminars in urology.

Low stage testis cancer is still potentially lethal.

D. Swanson, 1995, The Journal of urology.

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.

Wassim Kassouf, C. Dinney, M. Munsell, 2006, The Journal of urology.

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.

V. Margulis, P. Tamboli, E. Jonasch, 2008, The Journal of urology.

Diagnostic value of surgical testicular biopsy after therapy for acute lymphocytic leukemia.

L. Frankel, M. Hudson, D. Swanson, 1985, The Journal of pediatrics.

Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Michael J. Zelefsky, Thomas W. Feeley, Peter F. Orio, 2015, Brachytherapy.

Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.

V. Margulis, P. Tamboli, C. Wood, 2007, The Journal of urology.

Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer.

R. Babaian, A. V. von Eschenbach, K. Wishnow, 1987, The Journal of urology.

A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder.

H. Grossman, C. Dinney, J. Slaton, 1999, The Journal of urology.

Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy.

C. Dinney, A. Pollack, G. Zagars, 1997, International journal of radiation oncology, biology, physics.

915: The Case for Early Cystectomy in Non-Muscleinvasive Micropapillary Transitional Cell Carcinoma of the Bladder

R. Millikan, C. Dinney, A. Kamat, 2005 .

Medical castration using megestrol acetate and minidose estrogen.

R. Babaian, A. V. von Eschenbach, K. Wishnow, 1988, Urology.

Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.

T. Pugh, M. Munsell, R. Kudchadker, 2015, Brachytherapy.

Radical cystectomy for invasive bladder cancer in the octogenarian.

H. Grossman, R. Babaian, L. Pisters, 2001, Oncology reports.

Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy.

R. Kudchadker, S. Frank, T. Bruno, 2011, Brachytherapy.

Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?

D. Kuban, Andrew K. Lee, R. Kudchadker, 2008, International journal of radiation oncology, biology, physics.

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

D. Kuban, S. McGuire, K. Hoffman, 2018, International journal of radiation oncology, biology, physics.

Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.

D. Kuban, S. McGuire, Andrew K. Lee, 2013, Brachytherapy.

Bilateral testicular metastases from prostate carcinoma: gray‐scale and color Doppler sonographic findings.

C. Logothetis, D. Swanson, J. Ro, 1995, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Renal cell carcinoma clinically involving adjacent organs

V. Margulis, P. Tamboli, C. Wood, 2007, Cancer.

A novel MRI marker for prostate brachytherapy.

Steven J Frank, Rajat J Kudchadker, James A Bankson, 2008, International journal of radiation oncology, biology, physics.

Antitumor effects of partially pure human leukocyte interferon in renal cell carcinoma

J. Quesada, J. Gutterman, D. Swanson, 1982 .

Outcomes after prostate brachytherapy are even better than predicted

J. Sylvester, P. Grimm, T. Pugh, 2012, Cancer.

Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.

D. Kuban, Andrew K. Lee, L. Levy, 2009, The Journal of urology.

Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.

T. Pugh, R. Kudchadker, S. Frank, 2012, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Outcomes in Prostate Cancer Brachytherapy as Monotherapy for Disease at the Prostate Base

D. Kuban, Andrew K. Lee, R. Kudchadker, 2009 .

Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma

E. Jonasch, C. Wood, S. Swisher, 2009, BJU international.

Long-term tumor control after brachytherapy for base-of-prostate cancer

D. Kuban, Andrew K. Lee, T. Pugh, 2011, Journal of contemporary brachytherapy.

Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.

T. Pugh, L. Levy, R. Kudchadker, 2012, International journal of radiation oncology, biology, physics.

Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.

R. Stafford, G. Ibbott, F. Mourtada, 2011, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.

T. Pugh, R. Kudchadker, P. Blanchard, 2017, Brachytherapy.

Laser welded vesicourethral anastomosis in an in vivo canine model: a pilot study.

A. Costello, L. Stephens, Anthony J Costello, 2002, The Journal of urology.

Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.

D. Kuban, Andrew K. Lee, P. Troncoso, 2012, Brachytherapy.

A pilot trial of vascular targeted photodynamic therapy for renal tissue.

S. Matin, L. Stephens, D. Swanson, 2008, The Journal of urology.

Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.

P. Pisters, B. Mian, L. Pisters, 2002, The Journal of urology.

Re : Location of Extrarenal Tumor Extension Does Not Impact Survival of Patients With pT 3 a Renal Cell Carcinoma

V. Margulis, P. Tamboli, S. Matin, 2008 .

Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.

D. Kuban, Andrew K. Lee, P. Troncoso, 2012, Brachytherapy.